NR4A1 recruits TGF-β target genes, SIN3A, and histone deacetylase 1 (HDAC1) to form a repressor complex, countering the TGF-β-mediated pro-fibrotic effects in diabetes (Ma et al., 2023). Here, TGFB1 is linked to diabetes mellitus.